« Previous
Next »
Heart & Lung: The Journal of Acute and Critical Care
Volume 39, Issue 3
, Pages 237-239
, May 2010
Successful treatment of saphenous venous graft thrombus by tirofiban infusion
References
- Mechanism of acute myocardial infarction in patients with prior coronary artery bypass grafting and therapeutic implications. Am J Cardiol. 1990;65:1292–1296
- . Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Circulation. 1985;71:699–708
- . Coronary angioplasty and intracoronary thrombolysis are of limited efficacy in resolving early intracoronary stent thrombosis. J Am Coll Cardiol. 1996;28:361–367
- Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol. 1995;75:778–782
- . Randomized evaluation of the TriActiv balloon protection flush and extraction system for the treatment of saphenous vein graft disease. J Am Coll Cardiol. 2005;46:1677–1683
- . Determinants of embolic protection device use: case study in the acceptance of a new medical technology. Catheter Cardiovasc Intervent. 2005;65:597–599
- The influence of abciximab use on clinical outcome after aortocoronary vein graft interventions. J Am Coll Cardiol. 1999;34:1163–1169
- Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trials. Circulation. 2002;106:3063–3067
- . Thrombus predicts ischemic complications during percutaneous coronary intervention in saphenous vein grafts: results from TARGET (Do Tirofiban and ReoPro Give Similar Efficacy? Trial). Catheter Cardiovasc Intervent. 2007;69:623–629
- Mechanical prevention of distal embolization during primary angioplasty: safety, feasibility, and impact on myocardial reperfusion. Circulation. 2003;108:171–176
- . The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease. Am J Med. 2000;109:224–237
- . Resolution of a spontaneous coronary artery thrombus with a new antiplatelet agent. Int Angiol. 2001;20:244–247
- . Treatment of intracoronary thrombus using tirofiban in a patient with normal coronary arteries. Jpn Heart J. 2004;45:343–346
- Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980;303:897–902
- . Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation. 1998;97:916–931
- The effect of tirofiban and clopidogrel pretreatment on outcome of old saphenous vein graft stenting in patients with acute coronary syndromes. Tohoku J Exp Med. 2005;206:7–13
- Recanalization of chronically occluded aortocoronary saphenous vein bypass grafts by extended infusion of urokinase: initial results and short-term clinical follow-up. J Am Coll Cardiol. 1991;18:1517–1523
- . Platelet IIb/IIIa antagonists followed by delayed stent implantation. A new treatment for vein graft lesions containing massive thrombus. Heart. 1999;81:434–437
- . Prolonged systemic delivery of tirofiban in a thrombus-laden saphenous vein graft. Int J Cardiovasc Intervent. 2003;5:92–94
PII: S0147-9563(09)00183-6
doi: 10.1016/j.hrtlng.2009.07.001
© 2010 Elsevier Inc. All rights reserved.
« Previous
Next »
Heart & Lung: The Journal of Acute and Critical Care
Volume 39, Issue 3
, Pages 237-239
, May 2010
